Inventor
GUSTAVSON LINDA M
US31 patents
⚠️ This page may combine multiple inventors who share the name “GUSTAVSON LINDA M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEORX CORP
20 patentsUS5608060AMar 4, 1997
Biotinidase-resistant biotin-DOTA conjugates
NEORX CORP100 citations98
US6015897AJan 18, 2000
Biotinamido-n-methylglycyl-seryl-o-succinamido-benzyl dota
NEORX CORP69 citations96
US5630996AMay 20, 1997
Two-step pretargeting methods using improved biotin-active agent conjugates
NEORX CORP51 citations96
US5283342AFeb 1, 1994
Biotinylated small molecules
NEORX CORP61 citations96
US5541287AJul 30, 1996
Pretargeting methods and compounds
NEORX CORP87 citations95
US5607659AMar 4, 1997
Directed biodistribution of radiolabelled biotin using carbohydrate polymers
NEORX CORP35 citations93
US5556982ASep 17, 1996
Metal radionuclide labeled proteins for diagnosis and therapy
NEORX CORP22 citations93
US5250666AOct 5, 1993
Radionuclide metal chelates for the radiolabeling of proteins
NEORX CORP25 citations93
US5164176ANov 17, 1992
Radionuclide metal chelates for the radiolabeling of proteins
NEORX CORP31 citations93
US6022966AFeb 8, 2000
Pretargeting methods and compounds
NEORX CORP28 citations92
US5955605ASep 21, 1999
Biotinidase resistant biotin-DOTA conjugates
NEORX CORP36 citations92
US5847121ADec 8, 1998
Production of nitro-benzyl-dota via direct peptide cyclization
NEORX CORP21 citations92
US5578287ANov 26, 1996
Three-step pretargeting methods using improved biotin-active agent
NEORX CORP33 citations92
US5175257ADec 29, 1992
Radiolabeled proteins for diagnostic or therapeutic use
NEORX CORP29 citations92
US5112953AMay 12, 1992
Radiolabeled proteins for diagnostic or therapeutic use
NEORX CORP30 citations92
US6709652B2Mar 23, 2004
Pretargeting methods and compounds
NEORX CORP8 citations74
US6287536B1Sep 11, 2001
Two-step pretargeting methods using improved bidtin-active agent conjugates
NEORX CORP10 citations74
US5783171AJul 21, 1998
Radionuclide metal N2 S2 chelates substituted with glucose and biotin moieties
NEORX CORP15 citations74
US6358490B2Mar 19, 2002
Three-step pretargeting methods and compounds
NEORX CORP6 citations63
US5684137ANov 4, 1997
S3 N chelating compounds for the radiolabeling of ligands, anti-ligands or other proteins
NEORX CORP0 citations42
NEUROGEN CORP
8 patentsUS7642267B2Jan 5, 2010
Benzimidazole and pyridylimidazole derivatives
NEUROGEN CORP20 citations92
US7160879B2Jan 9, 2007
Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1H-benzoimidazole analogues
NEUROGEN CORP26 citations90
US7253168B2Aug 7, 2007
Substituted 1-benzyl-4-substituted piperazine analogues
NEUROGEN CORP13 citations82
US6916819B2Jul 12, 2005
Benzimidazole and pyridylimidazole derivatives
NEUROGEN CORP5 citations73
US6953801B2Oct 11, 2005
Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
NEUROGEN CORP11 citations72
US7030144B2Apr 18, 2006
Substituted imidazole derivatives: GABAA receptor ligands
NEUROGEN CORP2 citations63
US7300945B2Nov 27, 2007
Benzimidazole and pyridylimidazole derivatives
NEUROGEN CORP0 citations51
US7241765B2Jul 10, 2007
Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
NEUROGEN CORP0 citations50